샘플 요청 목록

 카트 문의
시장보고서
상품코드
1514164

세계의 무바늘 약물 주입 시스템 시장

Needle-Free Drug Injection Systems
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 278 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 무바늘 약물 주입 시스템 시장은 2030년까지 299억 달러에 달할 전망

2023년에 159억 달러로 평가된 세계의 무바늘 약물 주입 시스템 시장은 2030년에는 299억 달러에 이를 전망이며, 분석 기간 2023년부터 2030년까지 CAGR은 9.4%로 성장할 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 제트 인젝터 기술은 CAGR 9.5%로 성장을 지속하고, 분석 기간 종료까지 95억 달러에 달할 것으로 예측됩니다. 신규 니들 프리 기술 분야의 성장률은 분석 기간 동안 CAGR 8.5%로 추정됩니다.

미국 시장은 42억 달러로 추정, 중국은 CAGR 12.5%로 성장 예측

미국의 무바늘 약물 주입 시스템 시장은 2023년 42억 달러로 평가되었습니다. 세계 2위 경제대국인 중국은 2030년까지 67억 달러 규모에 이를 것으로 예측되며, 분석 기간 2023년부터 2030년까지 CAGR은 12.5%로 전망됩니다. 다른 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 6.1%와 7.8%로 예측되고 있습니다. 유럽에서는 독일이 CAGR 약 7.2%로 성장할 것으로 예측됩니다.

무바늘 약물 주입 시스템-주요 동향 및 촉진요인

무바늘 약물 주입 시스템은 동물 건강 관리, 특히 양돈 산업에서 중요한 혁신이며, 기존의 주사 바늘을 대체하는 효과적인 옵션을 제공합니다. 이 기술은 동물의 건강 상태를 향상시키고, 경영 비용을 줄이고, 육류 생산의 전반적인 안전성을 향상시킵니다. 무바늘 시스템은 고압 제트 기류를 발생시키고 동물 조직에 침투시켜 약물이나 백신을 투여하고, 피내, 피하, 근육 내에 직접 투여합니다. 이 방법은 정확한 복용량과 복용 깊이를 보장할뿐만 아니라 다양한 동물의 크기에 적응하기 때문에 새끼 돼지에서 자란 멧돼지와 돼지까지 적합합니다. 이러한 시스템은 강력한 면역 반응을 유발하는 데 효과적이며 종종 기존 방법보다 우수하기 때문에 축산에서 표준 백신 접종 프로토콜과 치료법에 혁명을 일으킬 가능성이 강조됩니다.

무바늘 주사 기술의 도입은 기존의 주사기와 관련된 몇 가지 심각한 안전 문제를 해결합니다. 주사 바늘이 부러지는 위험을 제거함으로써 이러한 시스템은 식품의 안전성을 높이고 소비자의 건강을 보호합니다. 또한 주사 바늘을 사용하지 않기 때문에 돼지 번식 및 호흡기 증후군(PRRS)과 같은 질병의 만연으로 이어질 수 있는 주사 바늘로 인한 일반적인 문제인 가축 간의 2 차 오염 위험이 감소됩니다. 또한 이러한 시스템의 설계적 특징은 우발적인 자가주사와 농장노동자의 반복운동에 의한 부상을 최소화함으로써 사용자의 안전을 우선시하고 보다 안전하고 인체공학적 작업 환경에 기여합니다. 그러나 무바늘 주사기로의 전환은 초기 투자와 지속적인 유지 보수와 같은 직접 및 간접 비용을 신중하게 고려해야 합니다.

무바늘 약물 주입 시스템 시장의 성장은 약물전달 메커니즘과 장비의 인체 공학을 향상시키는 지속적인 기술 혁신과 같은 여러 요인에 의해 야기됩니다. 이러한 진보는 시스템을 보다 효율적이고 사용하기 쉽고 광범위한 채용을 촉진합니다. 바늘 주사 손상 및 관련 법적 책임을 줄이기 위한 엄격한 규제 및 안전 기준도 바늘을 사용하지 않는 시스템으로의 이동을 촉진합니다. 헬스케어 종사자의 지지와 침습이 적은 치료법을 요구하는 환자의 요구는 특히 주사 바늘을 싫어하는 사람들 사이에서 이러한 동향에 더욱 영향을 미치고 있습니다. 또한, 이러한 시스템을 디지털 의료 기록과 통합하면 환자 데이터 관리가 쉬워지고 워크플로우 효율성이 향상됩니다. 주사 바늘을 사용하지 않는 시스템은 특히 집단 예방 접종 프로그램의 비용 효율적이고 빠르고 쉬운 백신 투여를 실현합니다. 마지막으로, 이러한 시스템은 일회용 주사 바늘과 관련된 의료 폐기물을 줄임으로써 환경 지속가능성 목표에 부합하며 기술 효율성, 환자 편의성, 환경에 대한 배려가 점점 우선시 되고 있는 현대의 헬스케어 환경에 있어서, 그 매력을 두드러지게 하고 있습니다.

조사 대상 기업 예(총 52건)

  • AKRA Dermojet
  • Crossject SA
  • D'Antonio Consultants International, Inc.
  • Medical International Technologies, Inc.
  • National Medical Products, Inc.
  • PharmaJet
  • Zogenix, Inc.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향 및 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

AJY 24.07.24

Global Needle-Free Drug Injection Systems Market to Reach US$29.9 Billion by 2030

The global market for Needle-Free Drug Injection Systems estimated at US$15.9 Billion in the year 2023, is expected to reach US$29.9 Billion by 2030, growing at a CAGR of 9.4% over the analysis period 2023-2030. Jet Injectors Technology, one of the segments analyzed in the report, is expected to record a 9.5% CAGR and reach US$9.5 Billion by the end of the analysis period. Growth in the Novel Needle-Free Technology segment is estimated at 8.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.2 Billion While China is Forecast to Grow at 12.5% CAGR

The Needle-Free Drug Injection Systems market in the U.S. is estimated at US$4.2 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$6.7 Billion by the year 2030 trailing a CAGR of 12.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.1% and 7.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.2% CAGR.

Needle-Free Drug Injection Systems - Key Trends and Drivers

Needle-free drug injection systems represent a significant innovation in the realm of animal healthcare, particularly within the swine industry, offering a viable alternative to traditional needle-based injections. This technology enhances animal health outcomes, reduces operational costs, and improves the overall safety of meat production. Needle-free systems administer medications or vaccines by creating a high-pressure jet stream capable of penetrating animal tissue, delivering substances directly into intradermal, subcutaneous, or intramuscular layers. This method not only ensures precise dosage and depth of administration but also adapts to various animal sizes, making it suitable from piglets to full-grown boars and sows. The effectiveness of these systems in eliciting robust immune responses, often superior to traditional methods, underscores their potential to revolutionize standard vaccination protocols and therapeutic treatments in animal husbandry.

The implementation of needle-free injection technology addresses several significant safety concerns associated with conventional syringes. By eliminating the risk of needle breaks, these systems enhance food safety and protect consumer health, crucial for maintaining the integrity and marketability of meat products, especially in export markets. Furthermore, needle-free injections reduce the risk of cross-contamination between animals, a common issue with needle injections that can lead to the spread of diseases such as porcine reproductive and respiratory syndrome (PRRS). The design features of these systems also prioritize user safety by minimizing accidental self-injection and repetitive motion injuries among farm workers, contributing to a safer and more ergonomic work environment. However, the transition to needle-free technology requires careful consideration of the direct and indirect costs, including the initial investment and ongoing maintenance of the devices, which may be offset by long-term benefits such as reduced disease transmission and medication costs in larger operations.

The growth of the needle-free drug injection system market is driven by multiple factors, including continuous technological innovations that enhance drug delivery mechanisms and device ergonomics. These advancements make the systems more efficient and user-friendly, fostering broader adoption. Stricter regulatory and safety standards aimed at reducing needlestick injuries and related liabilities also promote the shift towards needle-free systems. Healthcare worker advocacy and patient demand for less invasive treatment options further influence this trend, especially among individuals with needle aversions. Additionally, the integration of these systems with digital health records facilitates better patient data management, enhancing workflow efficiency. Needle-free systems are particularly cost-effective for mass immunization programs, providing quick and easy vaccine administration. Lastly, these systems align with environmental sustainability goals by reducing medical waste associated with disposable needles, highlighting their appeal in modern healthcare settings where technological efficiency, patient comfort, and environmental considerations are increasingly prioritized.

Select Competitors (Total 52 Featured) -

  • AKRA Dermojet
  • Crossject SA
  • D'Antonio Consultants International, Inc.
  • Medical International Technologies, Inc.
  • National Medical Products, Inc.
  • PharmaJet
  • Zogenix, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Needle-Free Drug Injection Systems - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Chronic Diseases Throws the Spotlight on Needle-Free Drug Injection Systems
    • Growing Focus on Pain-Free Delivery Methods Spurs Growth
    • Advancements in Biologics Propel Growth in Needle-Free Drug Delivery
    • Increased Adoption of Home Healthcare Solutions Expands Addressable Market Opportunity
    • Innovations in Jet Injection Technology Strengthen Business Case for Needle-Free Systems
    • Growing Awareness of Needle Stick Injuries and Infections Sustains Growth
    • Here's the Story on the Transition from Conventional to Needle-Free Systems
    • Here's How New Formulations and Drugs Accelerate Demand for Needle-Free Technologies
    • Cost-Effectiveness and Efficiency of Needle-Free Systems Propel Market Expansion
    • Rising Use of Self-Administration Techniques Spurs Growth of Needle-Free Devices
    • Technological Advancements and Integration with Smart Technologies Drive Adoption
    • Expansion of Vaccination Programs Generates Demand for Needle-Free Solutions
    • Focus on Reducing Medical Waste Expands Market for Needle-Free Drug Delivery
    • Here's How Digital Health Trends Drive Adoption of Needle-Free Systems
    • Patient-Centric Approaches Propel Growth in Needle-Free Drug Delivery Market
    • Stringent Regulations on Conventional Needles Propel Shift to Needle-Free Technologies
    • Increasing Geriatric Population Spurs Growth in Needle-Free Drug Injection Systems
    • Here's the Story on the Evolution of Needle-Free Technology and its Market Impact
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Needle-Free Drug Injection Systems Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Needle-Free Drug Injection Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Needle-Free Drug Injection Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Jet Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Jet Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Jet Injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Novel Needle-Free by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Novel Needle-Free by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Novel Needle-Free by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Inhaler by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Inhaler by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Inhaler by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Transdermal Patch by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Transdermal Patch by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Transdermal Patch by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Insulin Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Insulin Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Insulin Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Pain Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Vaccine Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Vaccine Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Vaccine Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Pediatric Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Pediatric Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Pediatric Injections by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Needle-Free Drug Injection Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Needle-Free Drug Injection Systems by Technology - Percentage Breakdown of Value Sales for Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Needle-Free Drug Injection Systems by Application - Percentage Breakdown of Value Sales for Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Needle-Free Drug Injection Systems by Technology - Percentage Breakdown of Value Sales for Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Needle-Free Drug Injection Systems by Application - Percentage Breakdown of Value Sales for Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • Needle-Free Drug Injection Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Needle-Free Drug Injection Systems by Technology - Percentage Breakdown of Value Sales for Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch for the Years 2014, 2024 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Needle-Free Drug Injection Systems by Application - Percentage Breakdown of Value Sales for Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications for the Years 2014, 2024 & 2030
  • CHINA
    • Needle-Free Drug Injection Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Needle-Free Drug Injection Systems by Technology - Percentage Breakdown of Value Sales for Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch for the Years 2014, 2024 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for Needle-Free Drug Injection Systems by Application - Percentage Breakdown of Value Sales for Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • Needle-Free Drug Injection Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Needle-Free Drug Injection Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Needle-Free Drug Injection Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Needle-Free Drug Injection Systems by Technology - Percentage Breakdown of Value Sales for Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch for the Years 2014, 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Needle-Free Drug Injection Systems by Application - Percentage Breakdown of Value Sales for Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications for the Years 2014, 2024 & 2030
  • FRANCE
    • Needle-Free Drug Injection Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Needle-Free Drug Injection Systems by Technology - Percentage Breakdown of Value Sales for Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch for the Years 2014, 2024 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: France 16-Year Perspective for Needle-Free Drug Injection Systems by Application - Percentage Breakdown of Value Sales for Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • Needle-Free Drug Injection Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Needle-Free Drug Injection Systems by Technology - Percentage Breakdown of Value Sales for Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch for the Years 2014, 2024 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Needle-Free Drug Injection Systems by Application - Percentage Breakdown of Value Sales for Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Needle-Free Drug Injection Systems by Technology - Percentage Breakdown of Value Sales for Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch for the Years 2014, 2024 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Needle-Free Drug Injection Systems by Application - Percentage Breakdown of Value Sales for Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Needle-Free Drug Injection Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Needle-Free Drug Injection Systems by Technology - Percentage Breakdown of Value Sales for Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch for the Years 2014, 2024 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Needle-Free Drug Injection Systems by Application - Percentage Breakdown of Value Sales for Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Needle-Free Drug Injection Systems by Technology - Percentage Breakdown of Value Sales for Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch for the Years 2014, 2024 & 2030
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Spain 16-Year Perspective for Needle-Free Drug Injection Systems by Application - Percentage Breakdown of Value Sales for Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Needle-Free Drug Injection Systems by Technology - Percentage Breakdown of Value Sales for Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch for the Years 2014, 2024 & 2030
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Russia 16-Year Perspective for Needle-Free Drug Injection Systems by Application - Percentage Breakdown of Value Sales for Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Needle-Free Drug Injection Systems by Technology - Percentage Breakdown of Value Sales for Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch for the Years 2014, 2024 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of Europe 16-Year Perspective for Needle-Free Drug Injection Systems by Application - Percentage Breakdown of Value Sales for Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Needle-Free Drug Injection Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Needle-Free Drug Injection Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Needle-Free Drug Injection Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Needle-Free Drug Injection Systems by Technology - Percentage Breakdown of Value Sales for Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch for the Years 2014, 2024 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Needle-Free Drug Injection Systems by Application - Percentage Breakdown of Value Sales for Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Needle-Free Drug Injection Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Needle-Free Drug Injection Systems by Technology - Percentage Breakdown of Value Sales for Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch for the Years 2014, 2024 & 2030
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Australia 16-Year Perspective for Needle-Free Drug Injection Systems by Application - Percentage Breakdown of Value Sales for Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications for the Years 2014, 2024 & 2030
  • INDIA
    • Needle-Free Drug Injection Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 122: India Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: India 16-Year Perspective for Needle-Free Drug Injection Systems by Technology - Percentage Breakdown of Value Sales for Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch for the Years 2014, 2024 & 2030
    • TABLE 125: India Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: India 16-Year Perspective for Needle-Free Drug Injection Systems by Application - Percentage Breakdown of Value Sales for Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Needle-Free Drug Injection Systems by Technology - Percentage Breakdown of Value Sales for Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch for the Years 2014, 2024 & 2030
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: South Korea 16-Year Perspective for Needle-Free Drug Injection Systems by Application - Percentage Breakdown of Value Sales for Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Needle-Free Drug Injection Systems by Technology - Percentage Breakdown of Value Sales for Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 16-Year Perspective for Needle-Free Drug Injection Systems by Application - Percentage Breakdown of Value Sales for Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Needle-Free Drug Injection Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Needle-Free Drug Injection Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Needle-Free Drug Injection Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Needle-Free Drug Injection Systems by Technology - Percentage Breakdown of Value Sales for Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch for the Years 2014, 2024 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Latin America 16-Year Perspective for Needle-Free Drug Injection Systems by Application - Percentage Breakdown of Value Sales for Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Needle-Free Drug Injection Systems by Technology - Percentage Breakdown of Value Sales for Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch for the Years 2014, 2024 & 2030
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Argentina 16-Year Perspective for Needle-Free Drug Injection Systems by Application - Percentage Breakdown of Value Sales for Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Needle-Free Drug Injection Systems by Technology - Percentage Breakdown of Value Sales for Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch for the Years 2014, 2024 & 2030
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Brazil 16-Year Perspective for Needle-Free Drug Injection Systems by Application - Percentage Breakdown of Value Sales for Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Needle-Free Drug Injection Systems by Technology - Percentage Breakdown of Value Sales for Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch for the Years 2014, 2024 & 2030
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Mexico 16-Year Perspective for Needle-Free Drug Injection Systems by Application - Percentage Breakdown of Value Sales for Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Needle-Free Drug Injection Systems by Technology - Percentage Breakdown of Value Sales for Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch for the Years 2014, 2024 & 2030
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Rest of Latin America 16-Year Perspective for Needle-Free Drug Injection Systems by Application - Percentage Breakdown of Value Sales for Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Needle-Free Drug Injection Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Needle-Free Drug Injection Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Needle-Free Drug Injection Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Needle-Free Drug Injection Systems by Technology - Percentage Breakdown of Value Sales for Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch for the Years 2014, 2024 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Middle East 16-Year Perspective for Needle-Free Drug Injection Systems by Application - Percentage Breakdown of Value Sales for Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Needle-Free Drug Injection Systems by Technology - Percentage Breakdown of Value Sales for Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch for the Years 2014, 2024 & 2030
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Iran 16-Year Perspective for Needle-Free Drug Injection Systems by Application - Percentage Breakdown of Value Sales for Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Needle-Free Drug Injection Systems by Technology - Percentage Breakdown of Value Sales for Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch for the Years 2014, 2024 & 2030
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Israel 16-Year Perspective for Needle-Free Drug Injection Systems by Application - Percentage Breakdown of Value Sales for Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Needle-Free Drug Injection Systems by Technology - Percentage Breakdown of Value Sales for Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch for the Years 2014, 2024 & 2030
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Saudi Arabia 16-Year Perspective for Needle-Free Drug Injection Systems by Application - Percentage Breakdown of Value Sales for Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Needle-Free Drug Injection Systems by Technology - Percentage Breakdown of Value Sales for Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch for the Years 2014, 2024 & 2030
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: UAE 16-Year Perspective for Needle-Free Drug Injection Systems by Application - Percentage Breakdown of Value Sales for Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Needle-Free Drug Injection Systems by Technology - Percentage Breakdown of Value Sales for Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch for the Years 2014, 2024 & 2030
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Rest of Middle East 16-Year Perspective for Needle-Free Drug Injection Systems by Application - Percentage Breakdown of Value Sales for Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications for the Years 2014, 2024 & 2030
  • AFRICA
    • Needle-Free Drug Injection Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Needle-Free Drug Injection Systems by Technology - Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Needle-Free Drug Injection Systems by Technology - Percentage Breakdown of Value Sales for Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch for the Years 2014, 2024 & 2030
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Needle-Free Drug Injection Systems by Application - Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Africa 16-Year Perspective for Needle-Free Drug Injection Systems by Application - Percentage Breakdown of Value Sales for Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제